January 23, 2012

Helix BioPharma Corp. Announces that Institutional Shareholder Services Recommends Shareholders Vote for Management’s Director Nominees (PDF)

AURORA, Ontario, January 23, 2012 – Helix BioPharma Corp. (TSX, NYSE Amex, FSE: “Helix,” “HBP” or “the Company”) is pleased to announce that Institutional Shareholder Services (“ISS”) has recommended that shareholders vote FOR the slate of directors nominated by management, which includes Jack M. Kay, W. Thomas Hodgson, Donald H. Segal, Ewa Don-Siemion, Wojciech M. Kwiatek and Wayne Schnarr, at the upcoming annual meeting (“AGM”) on January 30, 2012.